Role of reactive oxygen intermediates in the decrease of hepatic cytochrome P450 activity by serum of humans and rabbits with an acute inflammatory reaction

被引:0
|
作者
El-Kadi, AOS [1 ]
Bleau, AM [1 ]
Dumont, I [1 ]
Maurice, H [1 ]
Du Souich, P [1 ]
机构
[1] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Serum of rabbits with a turpentine-induced acute inflammatory reaction (RSINFLA) and serum of humans with a viral infection (HSINF) were previously shown to diminish hepatic cytochrome P450 (P450) content and activity. To document the role of reactive oxygen intermediates in the serum-mediated decrease in P450 content and activity, hepatocytes of rabbits with an acute inflammatory reaction (H-INFLA) were incubated with RSINFLA and HSINF for 4 h, and total P450 content (spectrally measurable P450), P450 activity (assessed by estimating the formation of theophylline metabolites), and amount of CYP1A1, CYP1A2, and CYP3A6 proteins were measured. RSINFLA or HSINF decreased P450 content and activity without affecting the amount of CYP1A1 and -1A2 H-INFLA. Exposure of H-CONT or H-INFLA to hydrogen peroxide (0.01-1.0 mM) and sodium nitroprusside (0.01-1.0 mM) produced a dose-dependent decrease in P450 content and in the formation of theophylline metabolites without modifying the amount of CYP1A1 and CYP1A2, whereas lipid peroxidation increased. Incubation of L-NAME (0.05-1.0 mM), dimethylthiourea (6.25-50 mM), or N-acetylcysteine (0.01-1.0 mM) with H-INFLA partially prevented the decrease in P450 content and activity and the increased lipid peroxidation induced by RSINFLA and HSINF. On the other hand, 3-amino-1,2,4-triazole (10-100 mM) or diethyldithiocarbamate (1.0-10 mM) potentiated RSINFLA- and HSINF-mediated decreases in P450 content and activity and the increase in lipid peroxidation, without affecting the amount of CYP1A1 or -1A2; DL-buthionine-(S,R)-sulfoximine (2.5-25 mM) potentiated only the inhibition of 1,3-dimethyluric acid formation. It is concluded that reactive oxygen intermediates are implicated in the decrease of H-INFLA P450 content and activity induced by 4 h of exposure to RSINFLA or HSINF.
引用
收藏
页码:1112 / 1120
页数:9
相关论文
共 50 条
  • [41] SPECTRAL INTERMEDIATES IN REACTION OF OXYGEN WITH PURIFIED LIVER MICROSOMAL CYTOCHROME-P-450
    GUENGERICH, FP
    BALLOU, DP
    COON, MJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1976, 70 (03) : 951 - 956
  • [42] HEPATIC STEATOSIS IN MICE LACKING HEPATIC CYTOCHROME P450 ACTIVITY IS BILE SALT DEPENDENT
    Kunne, Cindy
    Acco, Alexandra
    Hohenester, Simon
    Duijst, Suzanne
    de Waart, Dirk R.
    Elferink, Ronald Oude
    HEPATOLOGY, 2011, 54 : 1155A - 1155A
  • [43] Mechanism-based inhibition of Alantolactone on human cytochrome P450 3A4 in vitro and activity of hepatic cytochrome P450 in mice
    Qin, Chong-Zhen
    Lv, Qiao-Li
    Wu, Na-Yiyuan
    Cheng, Lin
    Chu, Yun-Chen
    Chu, Tang-Yuan
    Hu, Lei
    Cheng, Yu
    Zhang, Xue
    Zhou, Hong-Hao
    JOURNAL OF ETHNOPHARMACOLOGY, 2015, 168 : 146 - 149
  • [44] Cryotrapped reaction intermediates of cytochrome P450 studied by radiolytic reduction with phosphorus-32
    Denisov, IG
    Makris, TM
    Sligar, SG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (15) : 11648 - 11652
  • [45] DECREASE IN HEPATIC CYTOCHROME-P-450 BY COBALT - EVIDENCE FOR A ROLE OF COBALT PROTOPORPHYRIN
    SINCLAIR, JF
    SINCLAIR, PR
    HEALEY, JF
    SMITH, EL
    BONKOWSKY, HL
    BIOCHEMICAL JOURNAL, 1982, 204 (01) : 103 - 109
  • [46] CONTRIBUTION OF HEPATIC CYTOCHROME-P450 SYSTEMS TO THE GENERATION OF REACTIVE OXYGEN SPECIES
    BONDY, SC
    NADERI, S
    BIOCHEMICAL PHARMACOLOGY, 1994, 48 (01) : 155 - 159
  • [47] "Drugs on oxygen": an update and perspective on the role of cytochrome P450 testing in pharmacology
    Tralau, Tewes
    Luch, Andreas
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2012, 8 (11) : 1357 - 1362
  • [48] Studies with the hepatic NADPH:: Cytochrome P450 reductase null mouse reveal the role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine
    Stiborova, M.
    Arlt, V. M.
    Phillips, D. H.
    Henderson, C. J.
    Wolf, C. R.
    Hodek, P.
    Hudecek, J.
    Frei, E.
    PROCEEDINGS OF THE 15TH INTERNATIONAL CONFERENCE ON CYTOCHROMES P450 - BIOCHEMISTRY, BIOPHYSICS AND FUNCTIONAL GENOMICS, 2007, : 129 - +
  • [49] Model studies of cytochrome P450: Reactive intermediates, O-O activation, and catalytic oxygenation
    Nam, W
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2003, 96 (01) : 34 - 34
  • [50] Effect of the treatment period with erythromycin on cytochrome P450 3A activity in humans
    Okudaira, Toshiaki
    Kotegawa, Tsutomu
    Imai, Hiromitsu
    Tsutsumi, Kimiko
    Nakano, Shigeyuki
    Ohashi, Kyoichi
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (07): : 871 - 876